Avient Biosciences Adopts New Name to Signal Move to 21 CFR Part 210 and Part 211 Compliance North Carolina-based company producing cannabinoid ingredients that meet pharmaceutical-grade cGMP criteria Wilson, N.C., (July 30, 2021) — The largest industrial hemp research, extraction and production company in the eastern U.S. has adopted a new name, Averix Bio, to signal […]
A LETTER FROM OUR CEO, MILES WRIGHT It’s an exciting time here at Averix Bio. After many years of planning and months of buildout, we are finally shipping our first products. Proud hardly even comes close to how I feel about our entire team! Over the past few months, I’ve heard from plenty of people
A Letter from our CEO, Miles Wright Read More »
AVERIX BIO LAUNCHES LARGEST CANNABINOID RESEARCH, EXTRACTION AND PRODUCTION CAMPUS IN EASTERN U.S. North Carolina-based company produces pharma- and food-grade CBD ingredients backed by AI-powered blockchain technology Wilson, N.C., (Oct. 13, 2020) — Averix Bio officially launched its 200,000-square-foot industrial hemp research and extraction facility in North Carolina’s Research Triangle region this week. Designed for full cGMP
The FDA and Cannabinoids: An Overview of Regulatory History in the U.S. At Averix Bio, we believe increased FDA regulation is necessary to ensure the safety and long-term viability of this industry. Cannabis-derived remedies have been used for centuries The use of the Cannabis sativa plant for medicinal and other purposes has been around
The FDA and Cannabinoids: An Overview of Regulatory History in the U.S. Read More »
